Literature DB >> 2062488

Laser photocoagulation for stage 3+ retinopathy of prematurity.

J A McNamara1, W Tasman, G C Brown, J L Federman.   

Abstract

Twenty-two infants with "threshold" stage 3+ retinopathy of prematurity (ROP) were entered into a prospective, randomized clinical trial to compare the efficacy of transscleral cryotherapy versus laser photocoagulation delivered by the indirect ophthalmoscope. Eighteen infants have been followed for at least 3 months. Fifteen of 16 eyes randomized to laser and 9 of 12 eyes randomized to cryotherapy showed regression. The results suggest that laser therapy is as effective as cryotherapy in the treatment of ROP (P = 0.285).

Entities:  

Mesh：

Year:  1991        PMID： 2062488     DOI： 10.1016/s0161-6420(91)32247-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


  29 in total

1.  Diode laser treatment of posterior retinopathy of prematurity.

Authors:  R Axer-Siegel; M Snir; D Cotlear; A Maayan; R Frilling; I Rosenbaltt; D Weinberger; I Kremer; L Sirota
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Non-ophthalmologist screening for retinopathy of prematurity.

Authors:  R A Saunders; M L Donahue; J E Berland; E L Roberts; B Von Powers; P F Rust
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Ophthaproblem. Retinopathy of prematurity.

Authors:  Clara Chan; Alan F Cruess; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2003-12       Impact factor: 3.275

4.  Cryotherapy for retinopathy of prematurity--a prospective study.

Authors:  R Robinson; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

5.  [Comparison of the anatomical and functional outcome after laser or cryotherapy for retinopathy of prematurity (ROP)].

Authors:  C Jandeck; U Kellner; H Heimann; M H Foerster
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

Review 6.  Screening for retinopathy of prematurity.

Authors:  A R Fielder; M I Levene
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

7.  Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser.

Authors:  I A Pearce; F C Pennie; L M Gannon; A M Weindling; D I Clark
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

8.  Retinopathy of prematurity in infants of birth weight > 2000 g after haemorrhagic shock at birth.

Authors:  C Jandeck; U Kellner; H Kössel; M Bartsch; H T Versmold; M H Foerster
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

Review 9.  Insulin-like growth factor-1 and anti-vascular endothelial growth factor in retinopathy of prematurity: has the time come?

Authors:  Andreas Stahl; Ann Hellstrom; Lois E H Smith
Journal:  Neonatology       Date:  2014-10-05       Impact factor: 4.035

10.  Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.

Authors:  Eric R Crouch; Raymond T Kraker; David K Wallace; Jonathan M Holmes; Michael X Repka; Janine E Collinge; Don L Bremer; Michael E Gray; Heather A Smith; Paul G Steinkuller
Journal:  JAMA Ophthalmol       Date:  2020-01-01       Impact factor: 7.389
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.